abstract |
The present invention relates to novel antibodies and fragments that bind to the V domain Ig inhibitor of T cell activation (VISTA), and methods of making and using the same. Methods of use include methods of treating cancers including leukemias, lymphomas, solid tumors, and melanomas. |